LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study)

NACompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

January 10, 2019

Primary Completion Date

February 28, 2023

Study Completion Date

February 28, 2023

Conditions
Sickle Cell Disease
Interventions
OTHER

Peer Mentoring [PM]

Virtual Peer Mentoring

OTHER

Structured Education Based Transition Program STE

Education-based program

Trial Locations (14)

10467

Montefiore Medical Center, The Bronx

23298

Virginia Commonwealth University (VCU), Richmond

27157

Wake Forest Baptist Hospital, Winston-Salem

27705

Duke University, Durham

27834

East Carolina University, Greenville

28204

Levine Cancer Institute, Charlotte

Novant Health, Charlotte

29605

Greenville Health System, Greenville

30322

Children's Healthcare of Atlanta/Emory University, Atlanta

33136

University of Miami, Miami

33701

Johns Hopkins All Children's Hospital, St. Petersburg

35233

University of Alabama at Birmingham, Birmingham

36617

University of South Alabama Health System, Mobile

40202

University of Louisville, Louisville

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

Atrium Health Levine Cancer Institute

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT03593395 - LCI-HEM-SCD-ST3P-UP-001: The Sickle Cell Trevor Thompson Transition Project (ST3P-UP Study) | Biotech Hunter | Biotech Hunter